Image 1 Image 2 Image 4 Image 5 Image 6

Montreal, Canada June 18th and June 19th, 2026

Join the #ELIXR26 retreat, where experts gather to discuss early-stage lung cancer, happening in person on June 18th and June 19th, 2026!

In collaboration with The McGill University Health Centre (Dr. Jonathan Spicer) and Le Centre Hospitalier De l’Université de Montréal (Dr. Normand Blais), we are thrilled to announce the third annual international conference entitled Early-stage Lung cancer International eXpert Retreat - #ELIXR26.

This 1.5 day conference will be held in Montreal on June 18th and June 19th, 2026. This year’s event includes some top names in early-stage lung cancer from a number of disciplines across the globe including Dr. Luis Corrales Rodriguez, Dr. Silvia Formenti, Dr. Gavitt Woodward and many others. We are happy to invite another impressive group of comprehensive and multi-disciplinary experts that share a common goal of improving outcomes for early-stage lung cancer patients and have active basic, translational and clinical research programs that delineate the path to achieve such improvements.

The goal of this meeting is to build a tightly knit network of international experts to align on several key topics in early-stage lung cancer with a specific focus on current challenges and knowledge gaps. Ideas that will improve outcomes for patients in the most rapid, effective, and meaningful way possible are the top objective.

Hosted By

  • profile-picture

    Dr. Jon Spicer

    Associate Professor, McGill University
    Medical Director McGill Thoracic Oncology Network

    Completed his Bachelor degree in Science at McGill University. He continued his medical training at McGill earning an MD, and completed his surgical internship at the University of British Columbia. He returned to McGill the to complete his general surgical training and earned a PhD in Experimental Surgery.

  • profile-picture

    Dr. Normand Blais

    Director of clinical research in thoracic oncology, Centre Hospitalier De l’Université de Montréal

    Major interest in correlative research aimed at personalized adaptation of cancer treatments. Direction of research in haemostasis-thrombosis, particularly applied to thrombotic issues related to cancer.

Past Speakers

ELIXR 2025 brought together the top experts in early-stage lung cancer from a number of disciplines across the globe including Drs. Henning Willers, Danja Sacic and Salma Jabbour to name a few.

For the full lineup, check out the ELIXR 2025 Speaker Bios

3 reasons to attend

01
Learn
Learn from experts in the field and enhance your knowledge.
02
Level up
Get informed on the future of patient care.
03
Network
Network with international leaders in the space.

Thank you to our sponsors